Is hydroxyurea leukemogenic in essential thrombocythemia?: Response

被引:0
|
作者
Fenaux, P [1 ]
Preudhomme, C [1 ]
Laï, JL [1 ]
Sterkers, Y [1 ]
机构
[1] CHU Lille, Dept Hematol, F-59037 Lille, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1460 / 1461
页数:2
相关论文
共 50 条
  • [1] Is hydroxyurea leukemogenic in essential thrombocythemia?
    Tefferi, A
    BLOOD, 1998, 92 (04) : 1459 - 1460
  • [2] HYDROXYUREA AND OTHER MYELOSUPPRESSIVE AGENTS IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA - ANALYSIS OF LEUKEMOGENIC POTENTIAL
    MURPHY, S
    PETERSON, P
    ILAND, HJ
    FRUCHTMAN, S
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 564 - 564
  • [3] Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
    Nand, S
    Stock, W
    Godwin, J
    Fisher, SG
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 52 (01) : 42 - 46
  • [4] TREATMENT RESPONSE AND COMPLICATIONS OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA RECEIVING HYDROXYUREA
    Sotiropoulos, D.
    Papalexandri, A.
    Tsirigotis, P.
    Pouli, A.
    Kyriazopoulos, P.
    Protopapa, M.
    Dervenoulas, I.
    Fassas, A.
    Anagnostopoulos, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 58 - 59
  • [5] Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature
    Liozon, E
    Brigaudeau, C
    Trimoreau, F
    Desangles, F
    Fermeaux, V
    Praloran, V
    Bordessoule, D
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (01) : 11 - 18
  • [6] Hydroxyurea for patients with essential thrombocythemia (ET).
    Case, D
    BLOOD, 1995, 86 (10) : 3156 - 3156
  • [7] Hydroxyurea in old patients with essential thrombocythemia
    Randi M.L.
    Ruzzon E.
    Piccoli A.
    Tezza F.
    Scapin M.
    Scandellari R.
    Fabris F.
    Aging Clinical and Experimental Research, 2008, 20 (4) : 376 - 380
  • [8] Hydroxyurea in old patients with essential thrombocythemia
    Randi, Maria Luigia
    Ruzzon, Elisabetta
    Piccoli, Antonio
    Tezza, Fabiana
    Scapin, Margherita
    Scandellari, Raffaella
    Fabris, Fabrizio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 20 (04) : 376 - 380
  • [9] Treatment of essential thrombocythemia with special emphasis on leukemogenic risk
    G. Finazzi
    T. Barbui
    Annals of Hematology, 1999, 78 : 389 - 392
  • [10] Treatment of essential thrombocythemia with special emphasis on leukemogenic risk
    Finazzi, G
    Barbui, T
    ANNALS OF HEMATOLOGY, 1999, 78 (09) : 389 - 392